

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.74807424 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.74807424 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.29604878 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.29604878 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.29115921 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.09723189 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.56331830 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.56331830 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.56331830 |
| 10 | complement activation, alternative pathway (GO:0006957) | 5.47227175 |
| 11 | protein carboxylation (GO:0018214) | 5.41229026 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.41229026 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.34750664 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.30710786 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.30328719 |
| 16 | regulation of protein activation cascade (GO:2000257) | 5.21971297 |
| 17 | urea metabolic process (GO:0019627) | 5.12183168 |
| 18 | urea cycle (GO:0000050) | 5.12183168 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.03316519 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 4.97563170 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.95720677 |
| 22 | regulation of complement activation (GO:0030449) | 4.93745030 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.92490972 |
| 24 | glyoxylate metabolic process (GO:0046487) | 4.86987223 |
| 25 | bile acid metabolic process (GO:0008206) | 4.64975372 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.64251159 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 4.61660732 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.52011060 |
| 29 | cysteine metabolic process (GO:0006534) | 4.46471641 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.46243338 |
| 31 | protein-lipid complex remodeling (GO:0034368) | 4.43035887 |
| 32 | macromolecular complex remodeling (GO:0034367) | 4.43035887 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 4.43035887 |
| 34 | plasma lipoprotein particle clearance (GO:0034381) | 4.42020024 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.40163663 |
| 36 | exogenous drug catabolic process (GO:0042738) | 4.39041463 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.38265359 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.37389054 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.37369012 |
| 40 | phospholipid efflux (GO:0033700) | 4.34376607 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.32021715 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.27200011 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.27200011 |
| 44 | cholesterol efflux (GO:0033344) | 4.20264201 |
| 45 | omega-hydroxylase P450 pathway (GO:0097267) | 4.18811031 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 4.15802420 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.14165158 |
| 48 | coenzyme catabolic process (GO:0009109) | 4.13618628 |
| 49 | glutamate metabolic process (GO:0006536) | 4.10180299 |
| 50 | epoxygenase P450 pathway (GO:0019373) | 4.09537201 |
| 51 | cellular ketone body metabolic process (GO:0046950) | 4.05730652 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.00209829 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 3.98362642 |
| 54 | negative regulation of sterol transport (GO:0032372) | 3.98362642 |
| 55 | keratan sulfate catabolic process (GO:0042340) | 3.95854002 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 3.92219182 |
| 57 | fibrinolysis (GO:0042730) | 3.91952000 |
| 58 | lysine metabolic process (GO:0006553) | 3.91563596 |
| 59 | lysine catabolic process (GO:0006554) | 3.91563596 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.90778161 |
| 61 | cellular glucuronidation (GO:0052695) | 3.88198835 |
| 62 | amine catabolic process (GO:0009310) | 3.84889585 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 3.84889585 |
| 64 | cofactor catabolic process (GO:0051187) | 3.82319947 |
| 65 | ethanol oxidation (GO:0006069) | 3.81388801 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 3.80622358 |
| 67 | regulation of sequestering of triglyceride (GO:0010889) | 3.80084218 |
| 68 | arginine metabolic process (GO:0006525) | 3.73695951 |
| 69 | complement activation (GO:0006956) | 3.70080719 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 3.69899954 |
| 71 | phospholipid homeostasis (GO:0055091) | 3.69402391 |
| 72 | aldehyde catabolic process (GO:0046185) | 3.67662540 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.65349930 |
| 74 | complement activation, classical pathway (GO:0006958) | 3.65021174 |
| 75 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.64790336 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.60891660 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.60467600 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 3.59877597 |
| 79 | uronic acid metabolic process (GO:0006063) | 3.56829913 |
| 80 | glucuronate metabolic process (GO:0019585) | 3.56829913 |
| 81 | protein activation cascade (GO:0072376) | 3.55897438 |
| 82 | opsonization (GO:0008228) | 3.54829096 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.51645778 |
| 84 | ovulation from ovarian follicle (GO:0001542) | 3.48468622 |
| 85 | ketone body metabolic process (GO:1902224) | 3.46925219 |
| 86 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44605649 |
| 87 | plasma lipoprotein particle organization (GO:0071827) | 3.43717276 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.43568015 |
| 89 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.43282022 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.39329200 |
| 91 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.38942180 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.38586633 |
| 93 | glycine metabolic process (GO:0006544) | 3.38254459 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.37955103 |
| 95 | drug catabolic process (GO:0042737) | 3.36668647 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.34830129 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.33600612 |
| 98 | sterol homeostasis (GO:0055092) | 3.33179102 |
| 99 | carboxylic acid catabolic process (GO:0046395) | 3.30430473 |
| 100 | organic acid catabolic process (GO:0016054) | 3.30430473 |
| 101 | negative regulation of protein activation cascade (GO:2000258) | 3.29215950 |
| 102 | NAD biosynthetic process (GO:0009435) | 3.28759790 |
| 103 | cytolysis (GO:0019835) | 3.27539636 |
| 104 | regulation of bile acid biosynthetic process (GO:0070857) | 3.26711225 |
| 105 | oxidative demethylation (GO:0070989) | 3.25381780 |
| 106 | protein-lipid complex subunit organization (GO:0071825) | 3.24329444 |
| 107 | serine family amino acid metabolic process (GO:0009069) | 3.23347806 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.22763069 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.22763069 |
| 110 | negative regulation of complement activation (GO:0045916) | 3.15761272 |
| 111 | negative regulation of gluconeogenesis (GO:0045721) | 3.14103269 |
| 112 | regulation of phospholipase A2 activity (GO:0032429) | 3.05361799 |
| 113 | ethanol metabolic process (GO:0006067) | 2.99110755 |
| 114 | S-adenosylmethionine metabolic process (GO:0046500) | 2.97818757 |
| 115 | extracellular fibril organization (GO:0043206) | 2.94817375 |
| 116 | valine metabolic process (GO:0006573) | 2.93858107 |
| 117 | low-density lipoprotein particle clearance (GO:0034383) | 2.88531253 |
| 118 | drug metabolic process (GO:0017144) | 2.80139397 |
| 119 | transcytosis (GO:0045056) | 2.77175538 |
| 120 | parturition (GO:0007567) | 2.75148626 |
| 121 | behavioral response to nicotine (GO:0035095) | 2.68606877 |
| 122 | positive regulation of glomerulus development (GO:0090193) | 2.68375623 |
| 123 | triglyceride catabolic process (GO:0019433) | 2.63857943 |
| 124 | positive regulation of fatty acid oxidation (GO:0046321) | 2.62599117 |
| 125 | retinal metabolic process (GO:0042574) | 2.59373357 |
| 126 | positive regulation of metanephros development (GO:0072216) | 2.54222611 |
| 127 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.53920279 |
| 128 | fatty acid transmembrane transport (GO:1902001) | 2.53035129 |
| 129 | fibril organization (GO:0097435) | 2.50460969 |
| 130 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.49874843 |
| 131 | flavonoid metabolic process (GO:0009812) | 2.47418532 |
| 132 | indole-containing compound metabolic process (GO:0042430) | 2.44395552 |
| 133 | acylglycerol catabolic process (GO:0046464) | 2.43956986 |
| 134 | neutral lipid catabolic process (GO:0046461) | 2.43956986 |
| 135 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.43006164 |
| 136 | amino acid salvage (GO:0043102) | 2.42275401 |
| 137 | L-methionine salvage (GO:0071267) | 2.42275401 |
| 138 | L-methionine biosynthetic process (GO:0071265) | 2.42275401 |
| 139 | positive regulation of lipid storage (GO:0010884) | 2.40317950 |
| 140 | protein homotrimerization (GO:0070207) | 2.37690134 |
| 141 | protein trimerization (GO:0070206) | 2.35793577 |
| 142 | adhesion of symbiont to host cell (GO:0044650) | 2.35283002 |
| 143 | virion attachment to host cell (GO:0019062) | 2.35283002 |
| 144 | interkinetic nuclear migration (GO:0022027) | 2.34931993 |
| 145 | acute-phase response (GO:0006953) | 2.33625279 |
| 146 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.33189736 |
| 147 | * primary alcohol metabolic process (GO:0034308) | 2.32827001 |
| 148 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.31982258 |
| 149 | positive regulation of sterol transport (GO:0032373) | 2.30637909 |
| 150 | positive regulation of cholesterol transport (GO:0032376) | 2.30637909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.53455642 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.78374809 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.68185656 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.63045066 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.45672425 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.52040466 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.20281800 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.72258603 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57368043 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.81970957 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.41461158 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.40710909 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06745476 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04309410 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97142851 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93715760 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.91175513 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89032674 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83821597 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77572091 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.71700359 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69880995 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.66939100 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63584005 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61997807 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60726254 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.53936664 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52126844 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49016085 |
| 30 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48043474 |
| 31 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45496872 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.45303191 |
| 33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44009309 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40740220 |
| 35 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40553654 |
| 36 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40553654 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39416054 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36648074 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36435954 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35217471 |
| 41 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.34731894 |
| 42 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.34731894 |
| 43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.34640394 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33811120 |
| 45 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32665093 |
| 46 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32233644 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28916900 |
| 48 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.27801899 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24806100 |
| 50 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.24538312 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24055689 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22933475 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22788207 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22666010 |
| 55 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21780995 |
| 56 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20543039 |
| 57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19933543 |
| 58 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19928348 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18139410 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18128927 |
| 61 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17942535 |
| 62 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16812909 |
| 63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16559400 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16464980 |
| 65 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16407584 |
| 66 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.15349162 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13060809 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.12502330 |
| 69 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12362408 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12320873 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11284201 |
| 72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09524386 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09482036 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07935477 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.06765192 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05137891 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04684942 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04684942 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04479099 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03309973 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.02582507 |
| 82 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02300094 |
| 83 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01508723 |
| 84 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00861631 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00854317 |
| 86 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00661685 |
| 87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00360340 |
| 88 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00360340 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99610868 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99104244 |
| 91 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99047922 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98467757 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97388790 |
| 94 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96550565 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96135592 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95946750 |
| 97 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95166269 |
| 98 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91500922 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91109122 |
| 100 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90511688 |
| 101 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89399684 |
| 102 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87188858 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85386517 |
| 104 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84181533 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82926049 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82751360 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81867243 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80733226 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80347455 |
| 110 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80262254 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80142757 |
| 112 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.78679726 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78485445 |
| 114 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76254919 |
| 115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75461979 |
| 116 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75178783 |
| 117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74994532 |
| 118 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73557413 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73038252 |
| 120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71588557 |
| 121 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.69780365 |
| 122 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.67853335 |
| 123 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67489275 |
| 124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67210239 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66832859 |
| 126 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.65876243 |
| 127 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.64507100 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64402753 |
| 129 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63862050 |
| 130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.63015945 |
| 131 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63011240 |
| 132 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.62560678 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.62057150 |
| 134 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.61339627 |
| 135 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.60954216 |
| 136 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60428757 |
| 137 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60338691 |
| 138 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60255948 |
| 139 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.59620616 |
| 140 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.59185324 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.58777765 |
| 142 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.58596674 |
| 143 | AR_25329375_ChIP-Seq_VCAP_Human | 0.58287984 |
| 144 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.57669775 |
| 145 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.57523417 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57322707 |
| 147 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.56758981 |
| 148 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.55533485 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55209837 |
| 150 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.54696701 |
| 151 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.54473625 |
| 152 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.54426320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.43161403 |
| 2 | MP0005360_urolithiasis | 6.61667765 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.70225773 |
| 4 | MP0005365_abnormal_bile_salt | 5.56470388 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.71714775 |
| 6 | MP0003252_abnormal_bile_duct | 3.70987573 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.50139909 |
| 8 | MP0009840_abnormal_foam_cell | 3.45907618 |
| 9 | MP0005083_abnormal_biliary_tract | 2.96457599 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.88597499 |
| 11 | MP0003195_calcinosis | 2.86146580 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.64211904 |
| 13 | MP0003646_muscle_fatigue | 2.53732143 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.53578513 |
| 15 | MP0005332_abnormal_amino_acid | 2.43896672 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.31358623 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.18381987 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.02063409 |
| 19 | MP0009697_abnormal_copulation | 2.01791229 |
| 20 | MP0000609_abnormal_liver_physiology | 1.94648781 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.92454296 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.86302800 |
| 23 | MP0001501_abnormal_sleep_pattern | 1.83335390 |
| 24 | * MP0002108_abnormal_muscle_morphology | 1.80900320 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.80292635 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.68922977 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.68770415 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.68228598 |
| 29 | MP0004145_abnormal_muscle_electrophysio | 1.58353223 |
| 30 | MP0004043_abnormal_pH_regulation | 1.57904493 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.57712749 |
| 32 | MP0002822_catalepsy | 1.57275425 |
| 33 | MP0003868_abnormal_feces_composition | 1.49653250 |
| 34 | MP0005275_abnormal_skin_tensile | 1.49552379 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47382537 |
| 36 | MP0002933_joint_inflammation | 1.45722736 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.36355065 |
| 38 | MP0005647_abnormal_sex_gland | 1.36248371 |
| 39 | MP0001764_abnormal_homeostasis | 1.34436982 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.33948774 |
| 41 | MP0009764_decreased_sensitivity_to | 1.32175709 |
| 42 | MP0005670_abnormal_white_adipose | 1.31164984 |
| 43 | MP0000604_amyloidosis | 1.30916457 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.30852717 |
| 45 | MP0000751_myopathy | 1.27901601 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.25777936 |
| 47 | MP0004130_abnormal_muscle_cell | 1.16421198 |
| 48 | MP0003690_abnormal_glial_cell | 1.15258894 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.14144529 |
| 50 | MP0009763_increased_sensitivity_to | 1.13246647 |
| 51 | MP0003011_delayed_dark_adaptation | 1.10918750 |
| 52 | MP0000598_abnormal_liver_morphology | 1.08619391 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.07612868 |
| 54 | MP0002254_reproductive_system_inflammat | 1.06779827 |
| 55 | MP0000343_altered_response_to | 1.06486159 |
| 56 | MP0008469_abnormal_protein_level | 1.05381406 |
| 57 | MP0000372_irregular_coat_pigmentation | 1.05289808 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.02718072 |
| 59 | MP0003186_abnormal_redox_activity | 0.99913016 |
| 60 | MP0005451_abnormal_body_composition | 0.99381899 |
| 61 | MP0004134_abnormal_chest_morphology | 0.98079246 |
| 62 | * MP0000230_abnormal_systemic_arterial | 0.93732169 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 0.93473423 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.93380241 |
| 65 | MP0003436_decreased_susceptibility_to | 0.92661225 |
| 66 | MP0003959_abnormal_lean_body | 0.92142662 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 0.92051429 |
| 68 | MP0003724_increased_susceptibility_to | 0.91974477 |
| 69 | MP0005620_abnormal_muscle_contractility | 0.90087552 |
| 70 | MP0006082_CNS_inflammation | 0.88748811 |
| 71 | MP0005508_abnormal_skeleton_morphology | 0.87618794 |
| 72 | MP0005334_abnormal_fat_pad | 0.87312294 |
| 73 | MP0004036_abnormal_muscle_relaxation | 0.84219458 |
| 74 | MP0002332_abnormal_exercise_endurance | 0.84113833 |
| 75 | MP0008004_abnormal_stomach_pH | 0.83683718 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.83202042 |
| 77 | MP0000639_abnormal_adrenal_gland | 0.82034346 |
| 78 | * MP0005369_muscle_phenotype | 0.81300068 |
| 79 | MP0005171_absent_coat_pigmentation | 0.80011037 |
| 80 | MP0002060_abnormal_skin_morphology | 0.79520534 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.79384425 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 0.79254985 |
| 83 | MP0003045_fibrosis | 0.78599046 |
| 84 | MP0003879_abnormal_hair_cell | 0.77520573 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.76687757 |
| 86 | MP0005448_abnormal_energy_balance | 0.76257368 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.75980040 |
| 88 | * MP0002970_abnormal_white_adipose | 0.75786230 |
| 89 | MP0000538_abnormal_urinary_bladder | 0.75525369 |
| 90 | MP0006054_spinal_hemorrhage | 0.74583441 |
| 91 | MP0000767_abnormal_smooth_muscle | 0.74247443 |
| 92 | * MP0002078_abnormal_glucose_homeostasis | 0.73272048 |
| 93 | MP0005646_abnormal_pituitary_gland | 0.72741192 |
| 94 | MP0001440_abnormal_grooming_behavior | 0.72450134 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.72088308 |
| 96 | MP0005390_skeleton_phenotype | 0.71394742 |
| 97 | MP0003123_paternal_imprinting | 0.71293709 |
| 98 | MP0009046_muscle_twitch | 0.70627452 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.70563358 |
| 100 | MP0004084_abnormal_cardiac_muscle | 0.70450497 |
| 101 | MP0002971_abnormal_brown_adipose | 0.70398153 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.70001104 |
| 103 | MP0001270_distended_abdomen | 0.69283752 |
| 104 | MP0001661_extended_life_span | 0.68389269 |
| 105 | MP0004883_abnormal_blood_vessel | 0.67064637 |
| 106 | MP0002735_abnormal_chemical_nociception | 0.66150082 |
| 107 | MP0009745_abnormal_behavioral_response | 0.65791748 |
| 108 | MP0004142_abnormal_muscle_tone | 0.64906500 |
| 109 | * MP0000163_abnormal_cartilage_morphology | 0.64352374 |
| 110 | MP0006276_abnormal_autonomic_nervous | 0.64001352 |
| 111 | MP0004484_altered_response_of | 0.63869102 |
| 112 | MP0002419_abnormal_innate_immunity | 0.63702766 |
| 113 | MP0005248_abnormal_Harderian_gland | 0.63337571 |
| 114 | MP0001958_emphysema | 0.62895824 |
| 115 | MP0008872_abnormal_physiological_respon | 0.62061101 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.61724773 |
| 117 | MP0009115_abnormal_fat_cell | 0.61007904 |
| 118 | MP0001243_abnormal_dermal_layer | 0.60644647 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.60362345 |
| 120 | MP0002106_abnormal_muscle_physiology | 0.60206825 |
| 121 | MP0005164_abnormal_response_to | 0.59875803 |
| 122 | MP0000749_muscle_degeneration | 0.59747496 |
| 123 | MP0002272_abnormal_nervous_system | 0.59319478 |
| 124 | MP0005408_hypopigmentation | 0.58140466 |
| 125 | * MP0003638_abnormal_response/metabolism_ | 0.58031834 |
| 126 | MP0009053_abnormal_anal_canal | 0.57745886 |
| 127 | MP0002090_abnormal_vision | 0.57733738 |
| 128 | MP0003075_altered_response_to | 0.56911614 |
| 129 | MP0005636_abnormal_mineral_homeostasis | 0.56785994 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.55988917 |
| 131 | MP0005535_abnormal_body_temperature | 0.55073954 |
| 132 | MP0003385_abnormal_body_wall | 0.53992216 |
| 133 | MP0003279_aneurysm | 0.53114703 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.51086935 |
| 135 | MP0005166_decreased_susceptibility_to | 0.50020765 |
| 136 | MP0005464_abnormal_platelet_physiology | 0.48835864 |
| 137 | MP0001756_abnormal_urination | 0.47989414 |
| 138 | MP0000249_abnormal_blood_vessel | 0.46652040 |
| 139 | MP0005395_other_phenotype | 0.44386939 |
| 140 | MP0005023_abnormal_wound_healing | 0.43751815 |
| 141 | MP0005257_abnormal_intraocular_pressure | 0.42820741 |
| 142 | MP0001879_abnormal_lymphatic_vessel | 0.42481632 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.42245981 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.41512281 |
| 145 | MP0002168_other_aberrant_phenotype | 0.41155673 |
| 146 | MP0002282_abnormal_trachea_morphology | 0.40591169 |
| 147 | MP0002295_abnormal_pulmonary_circulatio | 0.39678138 |
| 148 | MP0005266_abnormal_metabolism | 0.39263214 |
| 149 | MP0003787_abnormal_imprinting | 0.38812647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.73953117 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.15197822 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.09479325 |
| 4 | Complement deficiency (HP:0004431) | 6.07768981 |
| 5 | Xanthomatosis (HP:0000991) | 5.93574119 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.85153594 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.80244336 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.42416452 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.41289999 |
| 10 | Joint hemorrhage (HP:0005261) | 4.90088887 |
| 11 | Epidermoid cyst (HP:0200040) | 4.56075439 |
| 12 | Abnormality of complement system (HP:0005339) | 4.55141715 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.38668385 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19313444 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.18724608 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.18579329 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14742245 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.96512356 |
| 19 | Myocardial infarction (HP:0001658) | 3.77848190 |
| 20 | Hypercholesterolemia (HP:0003124) | 3.76006055 |
| 21 | Wrist flexion contracture (HP:0001239) | 3.75660170 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70215240 |
| 23 | Hyperammonemia (HP:0001987) | 3.69511472 |
| 24 | Fat malabsorption (HP:0002630) | 3.67570438 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.58327897 |
| 26 | Ketosis (HP:0001946) | 3.47861929 |
| 27 | Hyperglycinemia (HP:0002154) | 3.46969089 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.45850425 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45545563 |
| 30 | Glomerulonephritis (HP:0000099) | 3.42215698 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.41107022 |
| 32 | Arthropathy (HP:0003040) | 3.35600021 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.34385692 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.28291857 |
| 35 | Aortic aneurysm (HP:0004942) | 3.27502166 |
| 36 | Aortic dissection (HP:0002647) | 3.24744417 |
| 37 | Skin nodule (HP:0200036) | 3.14295506 |
| 38 | Hepatoblastoma (HP:0002884) | 3.13477889 |
| 39 | Mitral stenosis (HP:0001718) | 3.12276648 |
| 40 | Spontaneous abortion (HP:0005268) | 3.07759553 |
| 41 | Enlarged kidneys (HP:0000105) | 3.07386604 |
| 42 | Hyperglycinuria (HP:0003108) | 3.06203945 |
| 43 | Spastic diplegia (HP:0001264) | 3.00712988 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.00085613 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.00085613 |
| 46 | Increased corneal curvature (HP:0100692) | 2.98864952 |
| 47 | Keratoconus (HP:0000563) | 2.98864952 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.98038206 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.86583187 |
| 50 | Steatorrhea (HP:0002570) | 2.85040733 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.79614024 |
| 52 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.75712075 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.72079258 |
| 54 | Striae distensae (HP:0001065) | 2.72009660 |
| 55 | Thyroid-stimulating hormone excess (HP:0002925) | 2.65800093 |
| 56 | Hyperbilirubinemia (HP:0002904) | 2.62285511 |
| 57 | Round ear (HP:0100830) | 2.56879439 |
| 58 | Mutism (HP:0002300) | 2.49088716 |
| 59 | Bone cyst (HP:0012062) | 2.45474545 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.43981490 |
| 61 | Abnormality of purine metabolism (HP:0004352) | 2.43972959 |
| 62 | Pancreatic cysts (HP:0001737) | 2.43036264 |
| 63 | Soft skin (HP:0000977) | 2.39951651 |
| 64 | Ketoacidosis (HP:0001993) | 2.39443967 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.36381267 |
| 66 | Amyloidosis (HP:0011034) | 2.34788132 |
| 67 | Nephritis (HP:0000123) | 2.33247217 |
| 68 | Vascular calcification (HP:0004934) | 2.32550464 |
| 69 | Gingival bleeding (HP:0000225) | 2.32443754 |
| 70 | Pancreatic fibrosis (HP:0100732) | 2.31163548 |
| 71 | Neonatal hypoglycemia (HP:0001998) | 2.27062307 |
| 72 | Corneal dystrophy (HP:0001131) | 2.26619025 |
| 73 | Hydroxyprolinuria (HP:0003080) | 2.26198938 |
| 74 | Abnormality of proline metabolism (HP:0010907) | 2.26198938 |
| 75 | Oligomenorrhea (HP:0000876) | 2.26110241 |
| 76 | Inability to walk (HP:0002540) | 2.25314526 |
| 77 | Distal arthrogryposis (HP:0005684) | 2.24167081 |
| 78 | Diastasis recti (HP:0001540) | 2.23950389 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.22542291 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.22372687 |
| 81 | Abnormality of the renal cortex (HP:0011035) | 2.22088661 |
| 82 | Upper motor neuron abnormality (HP:0002127) | 2.21666868 |
| 83 | Delayed CNS myelination (HP:0002188) | 2.21407072 |
| 84 | Esophageal varix (HP:0002040) | 2.20922072 |
| 85 | Cholelithiasis (HP:0001081) | 2.20857711 |
| 86 | Metabolic acidosis (HP:0001942) | 2.18075802 |
| 87 | Decreased circulating renin level (HP:0003351) | 2.16240291 |
| 88 | Pulmonary artery stenosis (HP:0004415) | 2.16107297 |
| 89 | Abnormality of alanine metabolism (HP:0010916) | 2.14882367 |
| 90 | Hyperalaninemia (HP:0003348) | 2.14882367 |
| 91 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14882367 |
| 92 | Broad metatarsal (HP:0001783) | 2.10535438 |
| 93 | Hyperventilation (HP:0002883) | 2.09078985 |
| 94 | True hermaphroditism (HP:0010459) | 2.08071086 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.08018995 |
| 96 | Cholecystitis (HP:0001082) | 2.08018995 |
| 97 | Thrombophlebitis (HP:0004418) | 2.07957363 |
| 98 | Cerebral edema (HP:0002181) | 2.05766840 |
| 99 | Hypothermia (HP:0002045) | 2.04332736 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 2.03666108 |
| 101 | Lethargy (HP:0001254) | 2.02076362 |
| 102 | Menorrhagia (HP:0000132) | 2.01410318 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 2.00939372 |
| 104 | Acanthocytosis (HP:0001927) | 1.97906596 |
| 105 | Thyroiditis (HP:0100646) | 1.97817127 |
| 106 | Spontaneous hematomas (HP:0007420) | 1.96898284 |
| 107 | Tubulointerstitial fibrosis (HP:0005576) | 1.95435076 |
| 108 | Hypoglycemic seizures (HP:0002173) | 1.94810537 |
| 109 | Broad-based gait (HP:0002136) | 1.94359394 |
| 110 | Pancreatitis (HP:0001733) | 1.93208548 |
| 111 | Nausea (HP:0002018) | 1.93201089 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.92101335 |
| 113 | Axonal loss (HP:0003447) | 1.91706014 |
| 114 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91470754 |
| 115 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91470754 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91470754 |
| 117 | Hematochezia (HP:0002573) | 1.91311216 |
| 118 | Absent speech (HP:0001344) | 1.90763407 |
| 119 | Prolonged QT interval (HP:0001657) | 1.90749567 |
| 120 | Potter facies (HP:0002009) | 1.90073743 |
| 121 | Facial shape deformation (HP:0011334) | 1.90073743 |
| 122 | Cerebral aneurysm (HP:0004944) | 1.89315826 |
| 123 | Progressive inability to walk (HP:0002505) | 1.88779705 |
| 124 | Hip contracture (HP:0003273) | 1.88616451 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 1.88148094 |
| 126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86168901 |
| 127 | Dicarboxylic aciduria (HP:0003215) | 1.86168901 |
| 128 | Abnormal finger flexion creases (HP:0006143) | 1.84418162 |
| 129 | Calf muscle hypertrophy (HP:0008981) | 1.84119619 |
| 130 | Fair hair (HP:0002286) | 1.83649665 |
| 131 | Action tremor (HP:0002345) | 1.82797665 |
| 132 | Nephronophthisis (HP:0000090) | 1.82571912 |
| 133 | Abnormality of the gallbladder (HP:0005264) | 1.81077801 |
| 134 | Vacuolated lymphocytes (HP:0001922) | 1.80760582 |
| 135 | Hypoplastic ischia (HP:0003175) | 1.80375580 |
| 136 | Limited hip movement (HP:0008800) | 1.80294573 |
| 137 | Hypokalemia (HP:0002900) | 1.77830602 |
| 138 | Opisthotonus (HP:0002179) | 1.77394309 |
| 139 | Gaze-evoked nystagmus (HP:0000640) | 1.77355520 |
| 140 | Vomiting (HP:0002013) | 1.77270244 |
| 141 | Abnormality of the renal medulla (HP:0100957) | 1.77078110 |
| 142 | Mesangial abnormality (HP:0001966) | 1.76498397 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.75630046 |
| 144 | Irritability (HP:0000737) | 1.75493998 |
| 145 | Gout (HP:0001997) | 1.75364409 |
| 146 | Pulmonary embolism (HP:0002204) | 1.74698983 |
| 147 | Esophageal neoplasm (HP:0100751) | 1.74630364 |
| 148 | Neoplasm of head and neck (HP:0012288) | 1.74630364 |
| 149 | Infantile muscular hypotonia (HP:0008947) | 1.74435541 |
| 150 | Congenital sensorineural hearing impairment (HP:0008527) | 1.73935125 |
| 151 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.73724651 |
| 152 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.73565171 |
| 153 | Conjunctival telangiectasia (HP:0000524) | 1.73212391 |
| 154 | Neonatal onset (HP:0003623) | 1.72786945 |
| 155 | Muscle fiber splitting (HP:0003555) | 1.72718617 |
| 156 | Epiphyseal stippling (HP:0010655) | 1.72073942 |
| 157 | Abolished electroretinogram (ERG) (HP:0000550) | 1.70825933 |
| 158 | Joint stiffness (HP:0001387) | 1.70757702 |
| 159 | Absent phalangeal crease (HP:0006109) | 1.67976061 |
| 160 | Tubulointerstitial abnormality (HP:0001969) | 1.67938834 |
| 161 | Generalized aminoaciduria (HP:0002909) | 1.67668900 |
| 162 | Status epilepticus (HP:0002133) | 1.67660636 |
| 163 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.67624525 |
| 164 | Type 1 muscle fiber predominance (HP:0003803) | 1.67006560 |
| 165 | Pigmentary retinal degeneration (HP:0001146) | 1.66859418 |
| 166 | Polyphagia (HP:0002591) | 1.65906353 |
| 167 | Retinal atrophy (HP:0001105) | 1.65512451 |
| 168 | Tubular atrophy (HP:0000092) | 1.65342234 |
| 169 | Progressive cerebellar ataxia (HP:0002073) | 1.65032298 |
| 170 | Abnormality of the ischium (HP:0003174) | 1.64907071 |
| 171 | Bulbous nose (HP:0000414) | 1.64727632 |
| 172 | Abnormal EKG (HP:0003115) | 1.64603999 |
| 173 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61959806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.18082176 |
| 2 | SIK1 | 4.06752868 |
| 3 | ERN1 | 3.55098152 |
| 4 | ERBB4 | 3.51023066 |
| 5 | FGFR4 | 2.73527425 |
| 6 | INSRR | 2.57499546 |
| 7 | ACVR1B | 2.56968726 |
| 8 | TAOK3 | 2.44951114 |
| 9 | FRK | 2.37040751 |
| 10 | AKT3 | 2.35907174 |
| 11 | CASK | 2.25884390 |
| 12 | OBSCN | 2.19311955 |
| 13 | ADRBK2 | 2.12211761 |
| 14 | EPHA3 | 1.97795558 |
| 15 | NLK | 1.86459308 |
| 16 | MAP3K14 | 1.84173018 |
| 17 | IRAK3 | 1.81374980 |
| 18 | CAMKK2 | 1.70868817 |
| 19 | NUAK1 | 1.69727558 |
| 20 | MAP2K4 | 1.69360806 |
| 21 | GRK1 | 1.67480719 |
| 22 | TYK2 | 1.64450267 |
| 23 | MST1R | 1.60204547 |
| 24 | LATS1 | 1.57284994 |
| 25 | TGFBR2 | 1.54744503 |
| 26 | KIT | 1.54322114 |
| 27 | MARK1 | 1.52970256 |
| 28 | CAMK1D | 1.49257696 |
| 29 | TBK1 | 1.45596088 |
| 30 | JAK1 | 1.42520064 |
| 31 | WNK3 | 1.42292538 |
| 32 | PKN2 | 1.41308227 |
| 33 | PIK3CG | 1.37854692 |
| 34 | PTK6 | 1.35014910 |
| 35 | MAP4K2 | 1.28842570 |
| 36 | MAPK13 | 1.28413413 |
| 37 | NEK9 | 1.19266163 |
| 38 | JAK2 | 1.13245950 |
| 39 | SGK2 | 1.12807932 |
| 40 | PDK3 | 1.12263362 |
| 41 | PDK4 | 1.12263362 |
| 42 | STK38L | 1.12237316 |
| 43 | PDK2 | 1.11331123 |
| 44 | FLT3 | 1.09212472 |
| 45 | DAPK2 | 1.07577911 |
| 46 | TRPM7 | 1.04848929 |
| 47 | CAMK1 | 1.03376091 |
| 48 | ABL2 | 1.02957329 |
| 49 | ADRBK1 | 1.02165177 |
| 50 | PKN1 | 1.01699895 |
| 51 | CDC42BPA | 1.01250830 |
| 52 | IRAK4 | 0.99845475 |
| 53 | SGK3 | 0.99567611 |
| 54 | FGFR2 | 0.98916188 |
| 55 | PBK | 0.97607015 |
| 56 | PHKG2 | 0.96473174 |
| 57 | PHKG1 | 0.96473174 |
| 58 | STK3 | 0.95902584 |
| 59 | CCNB1 | 0.95735522 |
| 60 | FGFR3 | 0.92919019 |
| 61 | MYLK | 0.92641585 |
| 62 | CSF1R | 0.92343326 |
| 63 | GRK7 | 0.92157429 |
| 64 | CSNK1G1 | 0.91568140 |
| 65 | MAPK11 | 0.91357971 |
| 66 | IRAK1 | 0.89635328 |
| 67 | NTRK3 | 0.89472343 |
| 68 | PRKCZ | 0.88279441 |
| 69 | TNIK | 0.87451159 |
| 70 | CAMK1G | 0.87264954 |
| 71 | PDGFRB | 0.86582889 |
| 72 | PRKG1 | 0.85167912 |
| 73 | IRAK2 | 0.84742867 |
| 74 | GRK5 | 0.84495788 |
| 75 | TIE1 | 0.83363213 |
| 76 | MAP3K7 | 0.81476755 |
| 77 | PRKCG | 0.79370295 |
| 78 | PRKAA2 | 0.78780281 |
| 79 | TRIB3 | 0.78547475 |
| 80 | MAPKAPK3 | 0.76492007 |
| 81 | MAP3K4 | 0.75589175 |
| 82 | PRKCE | 0.74919999 |
| 83 | SIK3 | 0.74744128 |
| 84 | MAP2K3 | 0.74541772 |
| 85 | GSK3A | 0.73607627 |
| 86 | OXSR1 | 0.72314837 |
| 87 | MAP3K3 | 0.70330076 |
| 88 | DDR2 | 0.69597740 |
| 89 | PLK2 | 0.69278622 |
| 90 | CSNK1G2 | 0.68965229 |
| 91 | PAK3 | 0.68419533 |
| 92 | IGF1R | 0.67130116 |
| 93 | CHUK | 0.67028639 |
| 94 | DMPK | 0.66638531 |
| 95 | ERBB2 | 0.66487823 |
| 96 | DYRK3 | 0.66445628 |
| 97 | PDGFRA | 0.65856788 |
| 98 | EPHA4 | 0.64044146 |
| 99 | CSK | 0.63447484 |
| 100 | PRKACA | 0.63443781 |
| 101 | PRKCH | 0.60597150 |
| 102 | IKBKE | 0.60430211 |
| 103 | PINK1 | 0.60097674 |
| 104 | PIM1 | 0.59427411 |
| 105 | PRKACG | 0.59256057 |
| 106 | PRKAA1 | 0.59040250 |
| 107 | CDK6 | 0.58856292 |
| 108 | ERBB3 | 0.56865074 |
| 109 | BMPR1B | 0.56478594 |
| 110 | SGK494 | 0.53906174 |
| 111 | SGK223 | 0.53906174 |
| 112 | CAMK4 | 0.53706995 |
| 113 | CSNK1A1 | 0.53699430 |
| 114 | CAMK2A | 0.53032525 |
| 115 | CDK8 | 0.52488266 |
| 116 | EGFR | 0.51951847 |
| 117 | ABL1 | 0.51129407 |
| 118 | MKNK2 | 0.50828973 |
| 119 | MAPK12 | 0.50197229 |
| 120 | MAP2K6 | 0.49710415 |
| 121 | MAPK7 | 0.49474346 |
| 122 | KDR | 0.48694323 |
| 123 | DYRK2 | 0.48305642 |
| 124 | PRKACB | 0.47756038 |
| 125 | MAP2K1 | 0.47649887 |
| 126 | TXK | 0.46938597 |
| 127 | EPHB2 | 0.46641603 |
| 128 | CAMK2G | 0.46166153 |
| 129 | PRKCD | 0.45152442 |
| 130 | PRKD1 | 0.44952244 |
| 131 | LATS2 | 0.44681533 |
| 132 | MAPKAPK5 | 0.44494656 |
| 133 | MAPK4 | 0.44130898 |
| 134 | MATK | 0.42219719 |
| 135 | SGK1 | 0.42153655 |
| 136 | CSNK1G3 | 0.41887440 |
| 137 | EIF2AK2 | 0.41743733 |
| 138 | PIK3CA | 0.41434438 |
| 139 | MARK2 | 0.41337819 |
| 140 | RIPK1 | 0.41168016 |
| 141 | TNK2 | 0.39557679 |
| 142 | BMPR2 | 0.39257504 |
| 143 | IKBKB | 0.38907444 |
| 144 | LYN | 0.35861407 |
| 145 | TGFBR1 | 0.35630667 |
| 146 | MAP3K2 | 0.35429479 |
| 147 | FER | 0.34908598 |
| 148 | BLK | 0.34651512 |
| 149 | MAP2K7 | 0.32321295 |
| 150 | INSR | 0.30693501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.48820746 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35153733 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.20932103 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15471239 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.15414062 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94823602 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74645522 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53803386 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51582489 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40037619 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33681849 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33278546 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26987500 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24769575 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15594139 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02803885 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.02070094 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.97892316 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96711840 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.92305718 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91209322 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89133117 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.87943160 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85944080 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84125882 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80774549 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78055481 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75898982 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75073536 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57136368 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56845023 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46859938 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46501568 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.38550304 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37602499 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.35288290 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28377913 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.23155502 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22914720 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21971624 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21763511 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21237889 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17865790 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15161592 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11552405 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.08277286 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06774903 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01897010 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98540957 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97614192 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97269128 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94327826 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93449865 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91131391 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91055950 |
| 56 | Nicotine addiction_Homo sapiens_hsa05033 | 0.85790220 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82294136 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81089445 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78918500 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75735311 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75385784 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75209217 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.73522977 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73374583 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.72152277 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.66828625 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.65752046 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65192091 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58413171 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.55375873 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54844268 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53963639 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.53868795 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53298241 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52926754 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52873548 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52679614 |
| 78 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52052706 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51193448 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50958885 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49843196 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46816020 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.46304804 |
| 84 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45805891 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44490557 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.44487618 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43361626 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41035531 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.40471719 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38964097 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38854558 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38642515 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35768419 |
| 94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33501943 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.33202259 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32549011 |
| 97 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31740611 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31679080 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.30920556 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.29612934 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28738341 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.28105140 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27830153 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.26659662 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.22654514 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21477188 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.15987949 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12477704 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.11723284 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.11189087 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10547775 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.08519078 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06509877 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.05787981 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03302022 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.02841541 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02422944 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02342181 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.02043130 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.01111783 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.01080383 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00117696 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0900856 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0870733 |
| 125 | * AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0645498 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | -0.0636925 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0616825 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | -0.0546750 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0407397 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0243458 |

